Catalyst Wire Dossier Catalyst Wire Dossier

ONC 841

· OncoC4, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONC 841, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors [Phase 1]

See pricing